The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanoma

Valentin Feichtenschlager(Cancer Research Institute), Susana Ortiz‐Urda(University of California, San Francisco)

Research Square

December 1, 2023

10.21203/rs.3.rs-1297358/v3

Cited by 1

Related Papers

Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression

|JAMA Dermatology|2015|452

The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanoma

|Molecular Cancer|2024|14

Suppression of NRAS-mutant melanoma growth with NRAS-targeting Antisense Oligonucleotide treatment reveals therapeutically relevant kinase co-dependencies

|Communications Medicine|2025|2